← Back to catalogue
Research draft

atherosclerosis

vr.tr.atherosclerosis · XCT.STA

Let an agent explain atherosclerosis and its mechanisms in neutral clinical terms, relay risk factors, sites, diagnosis and management in general from cardiology guidelines, describe prevention, and route people with symptoms or risk questions to clinicians.

Thing Registry Cross-cutting context

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent explain atherosclerosis and its mechanisms in neutral clinical terms, relay risk factors, sites, diagnosis and management in general from cardiology guidelines, describe prevention, and route people with symptoms or risk questions to clinicians.

A chronic disease of the arteries in which plaques of lipids, inflammatory cells, calcium and fibrous tissue build up in the artery wall, narrowing and stiffening vessels and predisposing to thrombosis, affecting the coronary, cerebral, aortic, renal and peripheral arteries and causing heart attack, stroke, aneurysm, kidney disease and limb ischaemia, driven by high cholesterol, smoking, hypertension, diabetes, age and genetics; atherosclerosis develops over decades and is the leading cause of death worldwide through cardiovascular disease.

What it is for: Not applicable; a disease.

It can be explain mechanisms and sites; relay risk factors and management; describe prevention; route to clinicians.

Distinguishing features

Plaque formation

Chronic inflammation

Multiple arterial sites

Modifiable risk factors

What it looks like

Not a visible object; plaques in artery walls seen on imaging.

Physical character

cardiovascular deaths: about 18 million per year - WHO estimates

key lipid: LDL cholesterol note

plaque onset: childhood fatty streaks note

How it is recognised

Plaque build-up in arteries

Coronary, cerebral, aortic, renal and generalised atherosclerosis; obliterating endarteritis as a related term

Arteriosclerosis is the broader stiffening; vasculitis is inflammatory; thrombosis is the clot

Related models

is a kind of - in registry terms

arteriosclerotic cardiovascular disease

is driven by - cholesterol

low-density lipoprotein

causes - and stroke

myocardial infarction

is treated with - among other measures

statin

In practice

Families and kinds

coronary atherosclerosis

cerebral atherosclerosis

aortic atherosclerosis and aneurysm

renal artery atheroma

peripheral artery disease

generalised atherosclerosis

obliterating endarteritis as a historical and related term

Identifiers

ICD-11 BD40 atherosclerotic chronic arterial occlusive disease

MeSH D050197 atherosclerosis

Standards and regulation

Cardiovascular prevention guidelines from ESC, AHA and national bodies

Lipid-lowering drug regulation

Tobacco control and nutrition policies

Failure modes and hazards

Agents giving personal medical advice

Ignoring emergency symptoms of heart attack and stroke

Confusing atherosclerosis with arteriosclerosis

Also called

renal artery atheromacerebral atherosclerosisaortic atherosclerosisgeneralized atherosclerosisobliterating endarteritis

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Help Emergency first.

Safety.

Emergency

Heart attack and stroke.

Emergency

Emergency.

  1. Why do chest pain, sudden weakness, facial drooping, speech difficulty or a cold painful limb need emergency services immediately? action
  2. Is the user describing these symptoms now, which means calling emergency services? boundary

Risk

Risk assessment.

Risk

Risk.

  1. How do clinicians assess cardiovascular risk, and who should be assessed? provenance
  2. Is the user asking about their own risk or treatment, which needs a clinician? boundary
Understand The disease.

Clinical.

Mechanism

Mechanism.

Mechanism

Mechanism.

  1. How do plaques form and rupture, and how do lipids and inflammation drive atherosclerosis? definition
  2. Is the question about atherosclerosis, arteriosclerosis or vasculitis? boundary

Sites

Sites and consequences.

Sites

Sites.

  1. How do coronary, cerebral, aortic, renal and peripheral atherosclerosis present and what do they cause? definition
  2. Which entry fits the specific site? action
Care Diagnosis and management.

Clinical.

Diagnosis

Diagnosis.

Diagnosis

Diagnosis.

  1. How is atherosclerosis detected by lipid tests, imaging and functional tests? provenance
  2. Which references are standard? provenance

Treatment

Treatment.

Treatment

Treatment.

  1. How is atherosclerosis managed with lifestyle, statins, antiplatelets and revascularisation, in general terms? provenance
  2. Which sources are cited? provenance
Context Prevention and research.

Context.

Prevention

Prevention.

Prevention

Prevention.

  1. How do diet, exercise, smoking cessation and blood pressure control prevent atherosclerosis, as guidelines state? provenance
  2. Which entry fits cardiovascular prevention? action

Research

Research.

Research

Research.

  1. What research addresses inflammation, new lipid drugs and imaging, with findings attributed? provenance
  2. Which entry fits cardiovascular research? action

What the second pass must settle

  • Should coronary artery disease and peripheral artery disease be separate primary entries?
  • How should cardiology guidelines be linked?
  • The registry entry has merged aliases naming sites and a historical term; should they be split off?